BRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt

Reuters12-20 03:58

Dec 19 (Reuters) - Amgen Inc AMGN.O:

AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
AMGEN INC - INVESTED OVER $40 BILLION IN MANUFACTURING AND RESEARCH AND DEVELOPMENT SINCE 2018
AMGEN INC - EXPAND ITS DIRECT-TO-PATIENT PROGRAM, AMGENNOW™ TO INCLUDE AIMOVIG(®) (ERENUMAB-AOOE) AND AMJEVITA(®) (ADALIMUMAB-ATTO)
AMGEN INC: ALL THREE MEDICINES WILL ALSO BE OFFERED THROUGH TRUMPRX.GOV.
AMGEN INC: AIMOVIG & AMJEVITA WILL BE AVAILABLE AT A DISCOUNTED MONTHLY PRICE OF $299

Source text: ID:nPn8Z45Pxa

Further company coverage: AMGN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592194044?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-20 03:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592194044","market":"us","top_or_hot":-1,"title":"BRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Amgen Says Aimovig &amp; Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt </title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Amgen Inc <span>AMGN.O</span>:</p><ul><li><p>AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS</p></li><li><p>AMGEN INC - INVESTED OVER $40 BILLION IN MANUFACTURING AND RESEARCH AND DEVELOPMENT SINCE 2018</p></li><li><p>AMGEN INC -  EXPAND ITS DIRECT-TO-PATIENT PROGRAM, AMGENNOW™ TO INCLUDE AIMOVIG(®) (ERENUMAB-AOOE) AND AMJEVITA(®) (ADALIMUMAB-ATTO)</p></li><li><p>AMGEN INC: ALL THREE MEDICINES WILL ALSO BE OFFERED THROUGH TRUMPRX.GOV.</p></li><li><p>AMGEN INC: AIMOVIG &amp; AMJEVITA WILL BE AVAILABLE AT A DISCOUNTED MONTHLY PRICE OF $299</p></li></ul><p>Source text: <span>ID:nPn8Z45Pxa</span></p><p>Further company coverage: <span>AMGN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-20 03:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Amgen Says Aimovig &amp; Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt </title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Amgen Inc <span>AMGN.O</span>:</p><ul><li><p>AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS</p></li><li><p>AMGEN INC - INVESTED OVER $40 BILLION IN MANUFACTURING AND RESEARCH AND DEVELOPMENT SINCE 2018</p></li><li><p>AMGEN INC -  EXPAND ITS DIRECT-TO-PATIENT PROGRAM, AMGENNOW™ TO INCLUDE AIMOVIG(®) (ERENUMAB-AOOE) AND AMJEVITA(®) (ADALIMUMAB-ATTO)</p></li><li><p>AMGEN INC: ALL THREE MEDICINES WILL ALSO BE OFFERED THROUGH TRUMPRX.GOV.</p></li><li><p>AMGEN INC: AIMOVIG &amp; AMJEVITA WILL BE AVAILABLE AT A DISCOUNTED MONTHLY PRICE OF $299</p></li></ul><p>Source text: <span>ID:nPn8Z45Pxa</span></p><p>Further company coverage: <span>AMGN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUATNS37:1","article_id":"2592194044","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592194044","pubTimestamp":1766174338,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt Dec 19 (Reuters) - Amgen Inc AMGN.O:AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOW","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4581":"高盛持仓","BK4599":"减肥药","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0058720904.USD":"联博国际健康护理基金A","BK4566":"资本集团","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","AMGN":"安进","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC"},"translate_title":"简介-安进表示，根据与美国政府的协议，Aimovig和Amjevita将以每月299美元的折扣价出售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMGN":0.9},"content_text":"BRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt Dec 19 (Reuters) - Amgen Inc AMGN.O:AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTSAMGEN INC - INVESTED OVER $40 BILLION IN MANUFACTURING AND RESEARCH AND DEVELOPMENT SINCE 2018AMGEN INC -  EXPAND ITS DIRECT-TO-PATIENT PROGRAM, AMGENNOW™ TO INCLUDE AIMOVIG(®) (ERENUMAB-AOOE) AND AMJEVITA(®) (ADALIMUMAB-ATTO)AMGEN INC: ALL THREE MEDICINES WILL ALSO BE OFFERED THROUGH TRUMPRX.GOV.AMGEN INC: AIMOVIG & AMJEVITA WILL BE AVAILABLE AT A DISCOUNTED MONTHLY PRICE OF $299Source text: ID:nPn8Z45PxaFurther company coverage: AMGN.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592194044","isCrawlerRequest":true}